Found: 22
Select item for more details and to access through your institution.
Functions of the multi‐interacting protein KIDINS220/ARMS in cancer and other pathologies.
- Published in:
- Genes, Chromosomes & Cancer, 2018, v. 57, n. 3, p. 114, doi. 10.1002/gcc.22514
- By:
- Publication type:
- Article
Characterization of T-DM1-resistant breast cancer cells.
- Published in:
- Pharmacology Research & Perspectives, 2020, v. 8, n. 4, p. 1, doi. 10.1002/prp2.617
- By:
- Publication type:
- Article
Transcriptional and Metabolic Investigation in 5′-Nucleotidase Deficient Cancer Cell Lines.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 11, p. 2918, doi. 10.3390/cells10112918
- By:
- Publication type:
- Article
Cytosolic 5′-Nucleotidase II Is a Sensor of Energy Charge and Oxidative Stress: A Possible Function as Metabolic Regulator.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 1, p. 182, doi. 10.3390/cells10010182
- By:
- Publication type:
- Article
Expression of domains for protein-protein interaction of nucleotide excision repair proteins modifies cancer cell sensitivity to platinum derivatives and genomic stability.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2014, v. 41, n. 10, p. 817, doi. 10.1111/1440-1681.12282
- By:
- Publication type:
- Article
Enhanced migration of breast and lung cancer cells deficient for cN-II and CD73 via COX-2/PGE2/AKT axis regulation.
- Published in:
- Cellular Oncology (2211-3428), 2021, v. 44, n. 1, p. 151, doi. 10.1007/s13402-020-00558-w
- By:
- Publication type:
- Article
Synthesis and Studies of Potential Inhibitors of CD73 Based on a Triazole Scaffold.
- Published in:
- European Journal of Organic Chemistry, 2022, v. 2022, n. 21, p. 1, doi. 10.1002/ejoc.202101175
- By:
- Publication type:
- Article
Second‐Generation CD73 Inhibitors Based on a 4,6‐Biaryl‐2‐thiopyridine Scaffold.
- Published in:
- ChemMedChem, 2023, v. 18, n. 7, p. 1, doi. 10.1002/cmdc.202200594
- By:
- Publication type:
- Article
Synthesis of Substituted 5′‐Aminoadenosine Derivatives and Evaluation of Their Inhibitory Potential toward CD73.
- Published in:
- ChemMedChem, 2019, v. 14, n. 15, p. 1431, doi. 10.1002/cmdc.201900348
- By:
- Publication type:
- Article
A Proposed Methodology to Deal with the Impact of In Vitro Cellular Matrix on the Analytical Performances of a Targeted Metabolomic LC-HRMS Method.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 4, p. 3770, doi. 10.3390/ijms24043770
- By:
- Publication type:
- Article
Cytosolic 5′-Nucleotidase II Silencing in Lung Tumor Cells Regulates Metabolism through Activation of the p53/AMPK Signaling Pathway.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 13, p. 7004, doi. 10.3390/ijms22137004
- By:
- Publication type:
- Article
Cytosolic 5′-Nucleotidase II Silencing in a Human Lung Carcinoma Cell Line Opposes Cancer Phenotype with a Concomitant Increase in p53 Phosphorylation.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 7, p. 2115, doi. 10.3390/ijms19072115
- By:
- Publication type:
- Article
The Antitumor Activity of Combinations of Cytotoxic Chemotherapy and Immune Checkpoint Inhibitors Is Model-Dependent.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.02100
- By:
- Publication type:
- Article
Unexpected Growth-Promoting Effect of Oxaliplatin in Excision Repair Cross-Complementation Group 1 Transfected Human Colon Cancer Cells.
- Published in:
- Pharmacology, 2018, v. 102, n. 3/4, p. 161, doi. 10.1159/000491587
- By:
- Publication type:
- Article
A systemically administered detoxified TLR4 agonist displays potent antitumor activity and an acceptable tolerance profile in preclinical models.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1066402
- By:
- Publication type:
- Article
Évaluation de l'immunotoxicité en recherche et dans le cadre du développement biomédical.
- Published in:
- Biologie Aujourd'hui, 2022, v. 216, n. 3/4, p. 167, doi. 10.1051/jbio/2022020
- By:
- Publication type:
- Article
PARP Inhibitors and Proteins Interacting with SLX4.
- Published in:
- Cancers, 2023, v. 15, n. 3, p. 997, doi. 10.3390/cancers15030997
- By:
- Publication type:
- Article
Enhancing the activity of platinum-based drugs by improved inhibitors of ERCC1-XPF-mediated DNA repair.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The druggability of intracellular nucleotide-degrading enzymes.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Gemcitabine resistance due to deoxycytidine kinase deficiency can be reverted by fruitfly deoxynucleoside kinase, DmdNK, in human uterine sarcoma cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 4, p. 547, doi. 10.1007/s00280-006-0195-8
- By:
- Publication type:
- Article
Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 6, p. 447, doi. 10.1038/nrd4010
- By:
- Publication type:
- Article
Cytosolic 5’-Nucleotidase II Interacts with the Leucin Rich Repeat of NLR Family Member Ipaf.
- Published in:
- PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0121525
- By:
- Publication type:
- Article